Home/Filings/4/0001415889-22-001329
4//SEC Filing

Hall Brett Matthew 4

Accession 0001415889-22-001329

CIK 0001790340other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:33 PM ET

Size

5.3 KB

Accession

0001415889-22-001329

Insider Transaction Report

Form 4
Period: 2022-02-10
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Stock Option

    2022-02-10+83,10083,100 total
    Exercise: $9.66Exp: 2032-02-09Class A Common Stock (83,100 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026.

Issuer

Immuneering Corp

CIK 0001790340

Entity typeother

Related Parties

1
  • filerCIK 0001870437

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:33 PM ET
Size
5.3 KB